http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9316729-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cb28588d1ec955ee8078199803f1158
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4283
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42
filingDate 1993-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185596b47ecb00cbfb983013bc8ece53
publicationDate 1993-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9316729-A1
titleOfInvention Antibodies for and treatment to prevent or reduce the severity of xenograft rejection
abstract Anti-human IgM antibody; in particular, an anti-human mu chain antibody can be employed for reducing patient levels of natural antibodies which are xenoreactive to eliminate or reduce the severity of xenograft rejection.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6395958-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2322562-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127936-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5821117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6849448-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5849991-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022169415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6258998-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9520661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6603059-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2322562-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6700037-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3056517-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7201899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016203292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5785966-A
priorityDate 1992-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4863869-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453239607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129064614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127944238
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424429364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID82528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID82528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21872824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15979

Total number of triples: 60.